Conformational Flexibility Models for the Receptor in Structure Based Drug Design

M. L. Teodoro and L. E. Kavraki, “Conformational Flexibility Models for the Receptor in Structure Based Drug Design,” Current Pharmaceutical Design, vol. 9, pp. 1419–1431, 2003.

Abstract

The problem of incorporating protein flexibility in the routine in silico screening of large databases of small chemical compounds is still an unsolved and hard problem. The main reason behind this difficulty is the exponential explosion in computational complexity due to the inclusion of the large number of degrees of freedom that represent the receptor flexibility. In order to address this limitation several flexibility models for the receptor have been developed which try to limit the number of additional model parameters. These models can be roughly grouped divided into five different categories. These are the use of soft receptors which relax energetic penalties due to steric clashes, the selection of a few critical degrees of freedom in the receptor binding site, the use of multiple receptor structures either individually or by combining them using an averaging scheme, the use of modified molecular simulation methods, or the use of collective degrees of freedom as a new basis of representation for protein flexibility. All these flexible receptor models strive to balance an improvement in the accuracy of the docking predictions with an increase in computational cost. In addition, other challenges such as the development of accurate solvation models and scoring functions make the receptor flexibility problem even harder.

Publisher: http://dx.doi.org/10.2174/1381612033454595

PDF preprint: http://kavrakilab.org/publications/teodoro-kavraki2003conformational-flexibility-models.pdf